European Archives - Page 240 of 1269 - European Medical Journal

miRNA Signatures as Biomarkers for Haemophilic Arthropathy: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures could serve as biomarkers for hemophilic arthropathy.

Emerging Risks of Spinal Stenosis in Older People with Haemophilia: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, spinal stenosis is increasingly common in aging hemophilia patients.

Nurse-Led Education for Female Haemophilia Carriers: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, nurse-led education empowers female hemophilia carriers across life stages.

The Hidden Burden of RSV in Primary Care

A new study across five European countries highlights the impact of RSV on clinical outcomes, healthcare utilisation, and family life.

Pseudomonas Infection Triggers Lung Transplant Rejection Through Immune Disruption

Pseudomonas aeruginosa infection drives lung transplant rejection by inducing regulatory T cell death and promoting B cell responses.

Microplastics Found in Human Brains: An Alarming Link to Dementia

Microplastics are accumulating in human brains at increasing levels, with potential links to dementia and other neurological concerns.

Maintaining Healthy Weight Reduces Risk of Multiple Myeloma

A recent study found that patients with monoclonal gammopathy of undetermined significance who maintain a healthy weight have a lower risk of progression to multiple myeloma.

SAPIEN 3 Ultra RESILIA valve: 1-year real-world outcomes with significant mortality benefits for patients

SAPIEN 3 Ultra RESILIA valve shows significant 1-year benefits, including lower all-cause mortality (driven by lower PVL), stroke, and…

Benefit of Dual Immunotherapy in GI Cancers

This infographic summarises three ongoing studies that demonstrate the benefit of dual immunotherapy combination therapy compared…

Revolutionising Interventional Cardiology and Mental Health Through the Lens of Aviation

In this episode Jonathan welcomes William Lombardi, one of the leading innovators in chronic total occlusion percutaneous coronary intervention.